Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Ben M Eyck"'
Autor:
Maria J Valkema, Anne‐Marie Vos, Rachel S van derPost, Ariadne HAG Ooms, Lindsey Oudijk, Ben M Eyck, Sjoerd M Lagarde, Bas PL Wijnhoven, Bastiaan R Klarenbeek, Camiel Rosman, J Jan B vanLanschot, Michail Doukas
Publikováno v:
The Journal of Pathology: Clinical Research, Vol 9, Iss 4, Pp 322-335 (2023)
Abstract Oesophageal adenocarcinomas may show different histopathological patterns, including excessive acellular mucin pools, signet‐ring cells (SRCs), and poorly cohesive cells (PCCs). These components have been suggested to correlate with poor o
Externí odkaz:
https://doaj.org/article/466ad4fe0e77426db65ebbc7e2315116
Autor:
Charlène J. van der Zijden, Ben M. Eyck, Ate van der Gaast, Leni van Doorn, Joost J.M.E. Nuyttens, J. Jan B. van Lanschot, Bas P.L. Wijnhoven, Bianca Mostert, Sjoerd M. Lagarde
Publikováno v:
Contemporary Clinical Trials Communications, Vol 28, Iss , Pp 100934- (2022)
Background: FLOT and CROSS are effective neoadjuvant regimens for esophageal cancer patients. Chemotherapy (FLOT) is aimed to have merely a systemic effect whereas neoadjuvant chemoradiotherapy (CROSS) achieves good locoregional response with clinica
Externí odkaz:
https://doaj.org/article/11f5bfb8ec2d439a884eaa7e0d55bd6e
Autor:
Xiaobin Zhang, Ben M. Eyck, Yang Yang, Jun Liu, Yin-Kai Chao, Ming-Mo Hou, Tsung-Min Hung, Qingsong Pang, Zhen-Tao Yu, Hongjing Jiang, Simon Law, Ian Wong, Ka-On Lam, Berend J. van der Wilk, Ate van der Gaast, Manon C. W. Spaander, Roelf Valkema, Sjoerd M. Lagarde, Bas P. L. Wijnhoven, J. Jan B. van Lanschot, Zhigang Li
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-11 (2020)
Abstract Background After neoadjuvant chemoradiotherapy (nCRT) for esophageal cancer, high pathologically complete response (pCR) rates are being achieved especially in patients with squamous cell carcinoma (SCC). An active surveillance strategy has
Externí odkaz:
https://doaj.org/article/2843509b1b4946d9b515bcdbaadad6c4
Autor:
Ben M. Eyck, Berend J. van der Wilk, Maurice J.C. van der Sangen, Ate van der Gaast, J. Jan B. van Lanschot
Publikováno v:
Oesophagus and Stomach ISBN: 0192863592
Surgery has been the cornerstone of curative treatment for patients with locally advanced oesophageal cancer. Over the last decades, the addition of chemotherapy and radiotherapy to surgery has been extensively tested to improve survival outcomes. Se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::863e63bafc96cb159689703cff677193
https://doi.org/10.1093/med/9780192863591.003.0011
https://doi.org/10.1093/med/9780192863591.003.0011
Autor:
Ben M, Eyck, Xing, Gao, Yang, Yang, Berend J, van der Wilk, Ian, Wong, Bas P L, Wijnhoven, Jun, Liu, Sjoerd M, Lagarde, Lam, Ka-On, Maarten C C M, Hulshof, Zhigang, Li, Simon, Law, Yin Kai, Chao, J Jan B, van Lanschot, D, Nieboer
Publikováno v:
British Journal of Surgery, 109(12), 1312-1318. John Wiley & Sons Ltd.
The British journal of surgery, 109(12), 1312-1318. John Wiley and Sons Ltd
The British journal of surgery, 109(12), 1312-1318. John Wiley and Sons Ltd
Background Patients with different ethnic and genetic backgrounds may respond differently to anticancer therapies. This study aimed to assess whether patients with oesophageal squamous cell carcinoma (OSCC) treated with neoadjuvant chemoradiotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cefaeceee96eadf8e2741e0550d70d6
https://pure.eur.nl/en/publications/f54ff49d-16a2-4bc1-a1a1-98def1c1feda
https://pure.eur.nl/en/publications/f54ff49d-16a2-4bc1-a1a1-98def1c1feda
Autor:
Ben M Eyck, Maurice PHM Jansen, Bo Jan Noordman, Peggy N Atmodimedjo, Berend J van der Wilk, John WM Martens, Jean A Helmijr, Corine M Beaufort, Bianca Mostert, Michail Doukas, Bas PL Wijnhoven, Sjoerd M Lagarde, J Jan B van Lanschot, Winand NM Dinjens
Publikováno v:
Journal of Pathology, 259(1), 35-45. John Wiley & Sons Ltd.
Active surveillance instead of standard surgery after neoadjuvant chemoradiotherapy (nCRT) has been proposed for patients with oesophageal cancer. Circulating tumour DNA (ctDNA) may be used to facilitate selection of patients for surgery. We show tha
Autor:
Thomas N. Walsh, Berend J van der Wilk, Wayne L. Hofstetter, Carlo Castoro, Jaffer A. Ajani, Guillaume Piessen, Heidi Furlong, Bas P. L. Wijnhoven, Sjoerd M. Lagarde, J. Jan B. van Lanschot, Ben M Eyck, Sung-Bae Kim, Daan Nieboer, Jong H. Kim, Rita Alfieri
Publikováno v:
Annals of Surgery, 275(3), 467-476. Lippincott Williams & Wilkins
OBJECTIVE: To compare overall survival of patients with a cCR undergoing active surveillance versus standard esophagectomy.SUMMARY OF BACKGROUND DATA: One-third of patients with esophageal cancer have a pathologically complete response in the resecti
Autor:
P. P. L. O. Coene, Ben M Eyck, J. Jan B. van Lanschot, Bas P. L. Wijnhoven, Juanita A. Haagsma, Bo Jan Noordman, Berend J van der Wilk, Inge Spronk, Erwin van der Harst, Joos Heisterkamp, Sjoerd M. Lagarde
Publikováno v:
The British journal of surgery, 109(2), 169-171. John Wiley & Sons Ltd.
Over one-quarter of patients would choose not to undergo standard oesophagectomy again, at least 1 year after they underwent neoadjuvant chemoradiotherapy and standard oesophagectomy. These patients had worse short- and long-term health-related quali
Autor:
Ruben D. van der Bogt, Berend J. van der Wilk, Lindsey Oudijk, Erik J. Schoon, Gesina van Lijnschoten, Sietske Corporaal, Judith Nieken, Peter D. Siersema, Tanya M. Bisseling, Rachel S. van der Post, Rutger Quispel, Arjan van Tilburg, Liekele E. Oostenbrug, Robert G. Riedl, Lieke Hol, Mike Kliffen, Suzan Nikkessen, Ben M. Eyck, J. Jan B. van Lanschot, Michael Doukas, Manon C. W. Spaander
Publikováno v:
Endoscopy, 54(12), 1131-1138. Georg Thieme Verlag
Endoscopy, 54, 12, pp. 1131-1138
Endoscopy, 54, 1131-1138
Endoscopy, 54, 12, pp. 1131-1138
Endoscopy, 54, 1131-1138
Background Active surveillance after neoadjuvant treatment is increasingly implemented. The success of this strategy relies on the accurate detection of residual cancer. This study aimed to assess the diagnostic value of a second (bite-on-bite) biops
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc6ab36c91560fe6cc23b4e332f41631
https://cris.maastrichtuniversity.nl/en/publications/d8e98dfb-8b9e-45da-ad98-2e6fe0f03ec0
https://cris.maastrichtuniversity.nl/en/publications/d8e98dfb-8b9e-45da-ad98-2e6fe0f03ec0
Autor:
Berend J van der Wilk, Wendy M. J. Schreurs, J. Jan B. van Lanschot, Maria J. Valkema, Bas P. L. Wijnhoven, Manon C.W. Spaander, Roelf Valkema, Mark J. Roef, Michail Doukas, Ben M Eyck, Sjoerd M. Lagarde
Publikováno v:
Journal of Nuclear Medicine, 62(4), 486-492. Society of Nuclear Medicine and Molecular Imaging
Active surveillance for patients with esophageal cancer and a clinically complete response (cCR) after neoadjuvant chemoradiotherapy (nCRT) is being studied. Active surveillance requires accurate clinical response evaluations. 18F-FDG PET/CT might be